ACPE Activity Number: None
Release Date: July 15, 2020
Expirations Date: July 15, 2023
Activity Type: Knowledge-based
CE Credits: None
Activity Fee: Members/Non-Member – Free
Patients with opioid use disorder require close monitoring and consistent access to care. This activity will offer information and resources to ensure care for this patient population is not interrupted during the COVID-19 pandemic. Presenters include a pharmacist and physician with expertise in addiction medicine and staff from the National Academy of Medicine Action Collaborative on Countering the U.S. Opioid Epidemic.
- Describe risks to patient access to care and treatment for opioid use disorder (OUD) during COVID-19.
- List steps to keep patients with OUD and their providers safe during COVID-19.
- Outline regulatory and legislative allowances to improve patient access to care for OUD.
- Identify resources from the National Academy of Medicine Action Collaborative on Countering the US Opioid Epidemic.
Elizabeth Salisbury-Afshar, MD, MPH
Director, Center for Addiction Research and Effective Solutions (CARES)
American Institutes for Research (AIR)
Liz Bentley, MSJ, PharmD, BCPS
Director, Clinical Pharmacy Services
Kaiser Permanente Northwest
CoChair, Kaiser Permanente Controlled Substances Stewardship Workgroup
Aisha Salman, MPH
Associate Program Officer
Action Collaborative on Countering the U.S. Opioid Epidemic
National Academy of Medicine
Elizabeth Finkelman, MPP
Program Officer, Office of the President
Director, Action Collaborative on Countering the U.S. Opioid Epidemic
Director, Healthy Longevity Global Competition
The webinar will be moderated by ASHP staff member Anna Legreid Dopp, PharmD, Senior Director, Clinical Guidelines & Quality Improvement